Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 5,181 - 5,200 results of 18,313 for search 'significant ((((a decrease) OR (((nn decrease) OR (greatest decrease))))) OR (mean decrease))', query time: 0.52s Refine Results
  1. 5181
    Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR).

    Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR). by Bulelani L. Sizani (21485746)

    Published 2025
    Save to List
    Saved in:
  2. 5182
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  3. 5183
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  4. 5184
    Diverse regulatory gate forms.

    Diverse regulatory gate forms. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  5. 5185
    The results of self-organising map (SOM) clustering.

    The results of self-organising map (SOM) clustering. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  6. 5186
    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), randomized controlled trial (RCT).

    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  7. 5187
    Description of the study sites in the NRE.

    Description of the study sites in the NRE. by Jeong-Soo Gim (18058588)

    Published 2025
    Save to List
    Saved in:
  8. 5188
    Correlation analysis of red blood cell-platelet ratio and coagulation indicators.

    Correlation analysis of red blood cell-platelet ratio and coagulation indicators. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  9. 5189
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  10. 5190
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  11. 5191
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  12. 5192
    CONSORT flow diagram depicting participant flow through the trial.

    CONSORT flow diagram depicting participant flow through the trial. by Leigh V. Evans (19753987)

    Published 2025
    Save to List
    Saved in:
  13. 5193
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance training exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  14. 5194
    Total count of HiFi reads indicating gene variation in 24 cassava genotypes.

    Total count of HiFi reads indicating gene variation in 24 cassava genotypes. by Bulelani L. Sizani (21485746)

    Published 2025
    Save to List
    Saved in:
  15. 5195
    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n 

    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  16. 5196
    Weekly resistance training frequency over time for the DHA and placebo groups combined (n 

    Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Save to List
    Saved in:
  17. 5197
    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM.

    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  18. 5198
    The red blood cell-platelet ratio affects prognosis.

    The red blood cell-platelet ratio affects prognosis. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  19. 5199
    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization.

    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:
  20. 5200
    Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set.

    Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

    Published 2025
    Save to List
    Saved in:

Search Tools: